| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/27/2005 | CN1198932C Streptococcus pneumoniae antigens |
| 04/27/2005 | CN1198931C MOraxella catarrhalis BASB034 polypeptides and uses thereof |
| 04/27/2005 | CN1198929C Antibodies against interferon alpha/beta receptor |
| 04/27/2005 | CN1198927C Vasoactive amine binding molecules |
| 04/27/2005 | CN1198926C Nucleic acid fragments, recombinant vector containing the same method for promoting expression of structural gene by using the same |
| 04/27/2005 | CN1198912C Bleaching compositions comprising multiply-substd, protease variants |
| 04/27/2005 | CN1198845C Monoclonal antibody inducing programming apoptosis |
| 04/27/2005 | CN1198836C Nucleic acids encoding G-protein coupled receptor involved in sensory |
| 04/27/2005 | CN1198648C High affinity human monoclonal antibodies specific for RSV F-protein |
| 04/27/2005 | CN1198642C Pharmaceutical application of mammal cell kinetin synthetic inhibitory factor |
| 04/27/2005 | CN1198628C Conditioned cell culture medium compositions and method of use |
| 04/26/2005 | US6884877 Test for detecting a cashew allergy |
| 04/26/2005 | US6884871 Isolation and use of tissue growth-inducing Frzb protein |
| 04/26/2005 | US6884779 Hybrid screening analyzing |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/26/2005 | US6884623 Using plant virions for vaccine preparation; gene therapy |
| 04/26/2005 | US6884621 Multilayer carrier with hollow cavities, seeding cells; incubation |
| 04/26/2005 | US6884620 Genetic engineering |
| 04/26/2005 | US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 04/26/2005 | US6884616 DNA-construct for the tissue-specific expression of a blood coagulation factor |
| 04/26/2005 | US6884595 Test tumor cell modulation; analyzing chromosomes |
| 04/26/2005 | US6884585 Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor |
| 04/26/2005 | US6884576 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
| 04/26/2005 | US6884410 Interleukins; for suppressing reactions to alloantigens (graft-versus-host disease/tissue rejection) in organ/bone marrow transplants |
| 04/26/2005 | US6883958 For collecting and processing specimens of particulate matter-containing biological fluid, including depositing onto microscope slide or other surface a uniform layer of particulates therefrom (e.g., cells); diagnostic cytology |
| 04/26/2005 | CA2310854C Isolation and identification of novel polymerases |
| 04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
| 04/26/2005 | CA2165954C Prostaglandin receptor fp and dna encoding it |
| 04/26/2005 | CA2103573C Stamen-specific promoters from rice |
| 04/26/2005 | CA1341481C Transformation and foreign gene expression in brassica species |
| 04/24/2005 | CA2446391A1 Method for inducing t cells regulator with cd47 ligands |
| 04/21/2005 | WO2005036179A1 Assays for evaluating anti-osteoarthritic activity |
| 04/21/2005 | WO2005035778A1 PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF α1,6-FUCOSYLTRANSFERASE |
| 04/21/2005 | WO2005035769A2 Gene silencing by using micro-rna molecules |
| 04/21/2005 | WO2005035755A1 Method of introducing nucleic acid |
| 04/21/2005 | WO2005035742A2 Methods of preparing and using stem cell compositions and kits comprising the same |
| 04/21/2005 | WO2005035740A1 Genomically modified cell neutralized to serum-free system |
| 04/21/2005 | WO2005035739A1 Regeneration treatment system |
| 04/21/2005 | WO2005035738A1 Cell differentiation of adipose-derived precursor cells |
| 04/21/2005 | WO2005035737A1 Method of preparing cell concentrate and cell composition |
| 04/21/2005 | WO2005035736A1 Method of mucus removal and, used therein, cell treatment fluid and storage fluid |
| 04/21/2005 | WO2005035735A2 Programmable scaffold, and methods for making and using the same |
| 04/21/2005 | WO2005035734A1 Process for producing cell culture and cell culture |
| 04/21/2005 | WO2005035726A2 Multi-layered polymerizing hydrogels for tissue regeneration |
| 04/21/2005 | WO2005035721A2 Native immunoglobulin binding reagents and methods for making and using same |
| 04/21/2005 | WO2005035583A1 Antibody composition specifically binding to il-5 receptor |
| 04/21/2005 | WO2005035582A1 Composition of antibody capable of specifically binding ccr4 |
| 04/21/2005 | WO2005035581A1 COMPOSITION OF ANTIBODY CAPABLE OF SPECIFICALLY BINDING HUMAN VEGF RECEPTOR Flt-1 |
| 04/21/2005 | WO2005035576A2 Method of resisting osteoclast formation |
| 04/21/2005 | WO2005035562A1 Novel cell growth promoter |
| 04/21/2005 | WO2005034876A2 Use of cell lines to produce active therapeutic proteins |
| 04/21/2005 | WO2005034875A2 Method and material for enhance tissue-biomaterial integration |
| 04/21/2005 | WO2005034853A2 Uses of interferons with altered spatial structure |
| 04/21/2005 | WO2005034843A2 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 04/21/2005 | WO2005034625A1 Covalently attached collagen vi for cell attachment and proliferation |
| 04/21/2005 | WO2005034624A2 Microfabricated compositions and processes for engineering tissues containing multiple cell types |
| 04/21/2005 | WO2005020928A3 Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins |
| 04/21/2005 | WO2005017160A3 Mobilization of hematopoietic cells |
| 04/21/2005 | WO2005012509A3 Method for immunotherapy of tumors |
| 04/21/2005 | WO2005006944A9 Devices and methods for assessing spinal and implant motion and for optimizing alignment and movement |
| 04/21/2005 | WO2005001078A3 Regeneration and repair of neural tissue using postpartum-derived cells |
| 04/21/2005 | WO2004111610A3 Method and system for the analysis of high density cells samples |
| 04/21/2005 | WO2004108888A3 Micropositioning cells for tissue engineering |
| 04/21/2005 | WO2004098490A3 Mesoderm and definitive endoderm cell populations |
| 04/21/2005 | WO2004094586A3 Three-dimentional, flexible cell growth substrate and related methods |
| 04/21/2005 | WO2004090110A3 Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway |
| 04/21/2005 | WO2004085473A3 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 04/21/2005 | WO2004076608A3 Bioreactor and methods for tissue growth and conditioning |
| 04/21/2005 | WO2004072104A3 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
| 04/21/2005 | WO2004071462A3 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/21/2005 | WO2004066937A3 Antibodies specific for plasmacytoid dendritic cells |
| 04/21/2005 | WO2004009802A3 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/21/2005 | WO2004009768A3 Viral vectors containing recombination sites |
| 04/21/2005 | WO2003093418A3 Keratinocytes expressing exogenous angiogenic growth factors |
| 04/21/2005 | WO2003063801A3 Treatment of tumor cells for use in immunotherapy of cancer |
| 04/21/2005 | WO2003048349A8 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances |
| 04/21/2005 | WO2002099053A3 Slc22as as modifiers of the p53 pathway and methods of use |
| 04/21/2005 | WO2002092842A3 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | US20050086710 Method for generating recombinant human platelets for identifying therapeutic target proteins |
| 04/21/2005 | US20050085628 Centromere specific monoclonal antibody for use in detection or identification of chromosomal aberrations, and in elucidation of the structure or the mechanism of centromere |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050084971 Using trehalose metabolism as reporter function to identify transgenic plants |
| 04/21/2005 | US20050084969 Method for producing a recombinant polypeptide |
| 04/21/2005 | US20050084968 Pluripotent stem cell for use as tool in propagation of cells, tissue and organs to treat disease |
| 04/21/2005 | US20050084967 Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 04/21/2005 | US20050084966 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/21/2005 | US20050084965 Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids |
| 04/21/2005 | US20050084964 Progenitor cells which can be differentiated into hepatic, pancreatic and/or salivary gland tissues; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084963 Purification of lineage-specific cells and uses therefor |
| 04/21/2005 | US20050084962 Methods of treatment using electromagnetic field stimulated stem cells |
| 04/21/2005 | US20050084961 For hematopoietic stem cell transplants from adipose tissue |
| 04/21/2005 | US20050084960 Propgating human embryonic stem cells in birds and generating specific tissues for use in treatment preferential organ deficiencies; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084959 Expanding transgenic cord hematopoietic stem cells; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084958 Propagating animal muscle tissue in vitro for use in engineered meat product for human consumption; food processing |
| 04/21/2005 | US20050084936 Human regulatory proteins |
| 04/21/2005 | US20050084928 Transgenic cells comprising transfected glutamine synthetase gene for use as bioreactor in propagation of heterologous proteins |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |